Jialong Qi Selected Research

Autoantibodies

1/2020

Modified bacterial outer membrane vesicles induce autoantibodies for tumor therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jialong Qi Research Topics

Disease

8	Neoplasms (Cancer) 02/2024 - 12/2018
4	Infections 03/2023 - 10/2015
2	Bites and Stings (Sting) 02/2024 - 01/2022
2	Pneumonia (Pneumonitis) 03/2023 - 12/2018
2	Inflammation (Inflammations) 01/2023 - 01/2021
1	Low Back Pain (Lumbago) 03/2024
1	Pain (Aches) 03/2024
1	Spinal Stenosis (Stenosis, Spinal) 03/2024
1	Colorectal Neoplasms (Colorectal Cancer) 02/2024
1	Lung Neoplasms (Lung Cancer) 11/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2023
1	Rheumatoid Arthritis 01/2023
1	Adenocarcinoma 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Chickenpox 02/2021
1	Coinfection 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Lung Injury 01/2019

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 01/2022 - 12/2018
3	CytokinesIBA 03/2023 - 01/2019
2	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2022
2	NanovaccinesIBA 01/2022 - 12/2018
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2020 - 01/2020
2	Monoclonal AntibodiesIBA 01/2020 - 10/2015
1	Liposomes (Liposome)IBA 02/2024
1	DNA (Deoxyribonucleic Acid)IBA 02/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2024
1	Therapeutic UsesIBA 02/2024
1	Lovastatin (Mevacor)FDA LinkGeneric 02/2024
1	ErbB Receptors (EGF Receptor)IBA 11/2023
1	Gefitinib (Iressa)FDA Link 11/2023
1	SaltsIBA 09/2023
1	3-methyladenineIBA 03/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	EnzymesIBA 01/2023
1	HydrogelsIBA 01/2023
1	InterferonsIBA 01/2022
1	Interferon Type IIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	AntigensIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	CateninsIBA 01/2022
1	Herpes Zoster VaccineIBA 02/2021
1	Nucleic AcidsIBA 02/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Imipenem FDA Link 01/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	AutoantigensIBA 01/2020
1	AutoantibodiesIBA 01/2020
1	AntibodiesIBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Antimicrobial PeptidesIBA 01/2019
1	Tachypleus tridentatus tachyplesin peptideIBA 01/2019
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	Poly I-CIBA 12/2018
1	CPG-oligonucleotideIBA 12/2018
1	LipidsIBA 12/2018
1	Hyaluronic Acid (Hyaluronan)IBA 12/2018
1	CathelicidinsIBA 12/2018
1	CD4 Antigens (CD4 Antigen)IBA 10/2015

Therapy/Procedure

7	Immunotherapy 02/2024 - 01/2020
3	Therapeutics 02/2024 - 01/2019
1	Laminectomy 03/2024
1	Length of Stay 03/2024
1	Decompression 03/2024
1	Drug Therapy (Chemotherapy) 02/2024
1	Oral Administration 11/2023